Submission Details
| 510(k) Number | K950180 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 17, 1995 |
| Decision Date | March 15, 1995 |
| Days to Decision | 57 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Summary PDF |
K950180 is an FDA 510(k) clearance for the DUPONT DIMENSION(R) PSEUDOCHOLINESTERASE METHOD, a Acetylcholine Chloride, Specific Reagent For Pseudo Cholinesterase (Class I — General Controls, product code DLI), submitted by E.I. Dupont DE Nemours & Co., Inc. (Wilmington, US). The FDA issued a Cleared decision on March 15, 1995, 57 days after receiving the submission on January 17, 1995. This device falls under the Toxicology review panel. Regulated under 21 CFR 862.3240.
| 510(k) Number | K950180 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 17, 1995 |
| Decision Date | March 15, 1995 |
| Days to Decision | 57 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Summary PDF |
| Product Code | DLI — Acetylcholine Chloride, Specific Reagent For Pseudo Cholinesterase |
| Device Class | Class I — General Controls |
| CFR Regulation | 21 CFR 862.3240 |